ROCHESTER, N.Y., June 26, 2012 /PRNewswire/ -- Thermal Gradient, Inc., a developer of disposable ultra-fast DNA testing devices, announced today that it has initiated the manufacture of its next generation device. Robert Juncosa, the company’s Chief Technology Officer stated, “Our previous generation device was a huge success. It performs PCR, the critical step in almost all DNA tests, in less than eight minutes. This new device is capable of “real-time” PCR, a process used to determine the amount of initial DNA being tested. This is very important when testing for infectious diseases like HIV.”
Because of design improvements over the previous generation, the new device will is expected to perform better but will cost less to manufacture.
“Our recent breakthroughs and this new device position us as the premier technology for both point of care and high throughput clinical laboratory testing,” says CEO Joel Grover. “Because of our speed, low cost, and fundamental design, the hardware module required to perform a quantitative DNA test is small. This makes it easily scalable to achieve high throughput systems in a modest instrument footprint.”
The company will begin testing the new devices in the third quarter. Dr. Grover added, “When our internal testing is complete, we will then make cartridges and demonstration platforms available to diagnostic systems developers for their evaluation and assay optimization.”
About Thermal Gradient
Thermal Gradient develops devices and systems based on its patented technology that enables nucleic acid testing to be performed in minutes instead of an hour or more. Systems based on this technology can be developed for clinics and remote settings as well as for main-line diagnostic platforms for the clinical laboratory. For more information, please visit:
www.thermalgradient.com
Contact:
Joel Grover, Ph.D
Chief Executive Officer
Thermal Gradient, Inc.
585-248-9598
info@thermalgradient.com
SOURCE Thermal Gradient
